Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2011

View Archived Issues

Novel PAK inhibitors reported by Afraxis

WARF scientists present novel vitamin D receptor ligands

Novel hepatocyte growth factor receptor inhibitors designed

SYL-1001 confers analgesia in animal model of ocular pain

Hutchison MediPharma presents preclinical data on new small-molecule anticancer agents

New MAb targeting anti-Muellerian hormone type-2 receptor suppresses ovarian tumors in vivo

BiTE antibody MT-112/BAY-2010112 targets prostate cancer

Glaucoma candidate ATS-907 shows promising efficacy and safety profile

Immunetics receives NIH grant for clinical trials of immunoblot test for Chagas' disease

Debiopharm and Yale University enter licensing agreement for Debio-1036

Akebia Therapeutics completes phase IIa pilot study of AKB-6548 for anemia

New inhibitors of lysine-specific histone demethylase 1A and/or MAO-B claimed

Aquaporin-9 expression demonstrated in malignant glioma biopsies

Novel estrogen receptor beta ligands prepared at Karo Bio

Northwest Biotherapeutics recruits additional patients in DCVax-Brain trial

Almirall and Nycomed enter co-branding agreement for roflumilast in Spain

Sanofi-aventis and Medicines for Malaria Venture enter alliance to develop malaria treatments

Allergan and Molecular Partners sign license agreement for MP-0112 in ophthalmic indications

Pharming and Santarus amend protocol for phase III Rhucin study

Mologen expands inclusion criteria for pivotal study of MGN-1703 in colorectal cancer

Savient Pharmaceuticals files MAA with the EMA for Krystexxa in chronic gout

PharmaGap provides update on liposomal delivery formulations of GAP-107B8

Enrollment in KAEL-GemVax's phase III pancreatic cancer vaccine trial exceeds 1,000 patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...